Cardio-protective effects of carnitine in streptozotocin-induced diabetic rats

Cardiovascular Diabetology

Volumn 5, Issue , 2006, Pages

  Malone, John I ^a   Cuthbertson, David D ^a   Malone, Michael A ^a   Schocken, Douglas D ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; DOBUTAMINE; FATTY ACID; HEMOGLOBIN A1C; INSULIN ZINC SUSPENSION; STREPTOZOCIN; CARDIOTONIC AGENT; GLYCOSYLATED HEMOGLOBIN;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ECHOCARDIOGRAPHY; FATTY ACID BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HEART RATE; HYPERGLYCEMIA; MALE; NONHUMAN; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; SUPPLEMENTATION; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HEART VENTRICLE; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; CARDIOTONIC AGENTS; CARNITINE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOBUTAMINE; ECHOCARDIOGRAPHY; FATTY ACIDS, NONESTERIFIED; HEART RATE; HEART VENTRICLES; HEMOGLOBIN A, GLYCOSYLATED; MALE; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 32644442102     PISSN: 14752840     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2840-5-2     Document Type: Article

References (26)

1. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W: Diabetes and cardiovascular disease - A statement for healthcare professionals from the American heart association. Circulation 1999, 100: 1134-1146.
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993, 329:977-986.
3. Malone JI, Schocken DD, Morrison AD, Gilbert-Barness E: Diabetic cardiomyopathy and carnitine deficiency. Jour Diab Comp 1999, 13(2):86-89.
4. Hoit BD, Castro C, Bultron G, Knight S, Matlib MA: Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail 1999, 5(4):324-333.
5. Van Buren T, Schiereck P, De Ruiter GJW, Gispen WH, De Wildt DJ: Vagal efferent control of electrical properties of the heart in experimental diabetes. Acta, Diabetologia 1998, 35:19-25.
6. Aring AM, Jones DE, Falko JM: Evaluation and prevention of diabetic Neuropathy. AM FAM Physician 2005, 71:2123-8. 2129-30
7. Malone JI, Lowitt S, Korthals JK, Salem A, Miranda C: The effect of hyperglycemla on nerve conduction and structure is age dependent. Diabetes 1996, 45:209-215.
8. Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S: Carnitine deficiency in children and adolescents with type I diabetes. J Diabetes Complications 2004, 18(5):271-4.
9. The guide for the care and use of laboratory animal. NIH Publication; 1985:85-32.
10. McGarry JD, Foster DW: An Improved and simplified radio-isotopic assay for determination of free and esterified carnitine. J Lipid Res 1976, 17:277-281.
11. Duncombe WG, Rising TJ: Quantitative extraction and determination of nonesterified fatty acids In plasma. Journal of Lipid Research 1973, 14(2):258-261.
12. Bonferroni CE: Teoria statistica delle classi e calcolo delle probabilità. Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze 1936, 8:3-62.
13. Schaan BD, Dall'Ago P, Maeda CY, Ferlin E, Fernandes TG, Schmid H, Irigoyen MC: Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats. Broz J Med Biol Res 2004, 37(12):1895-902.
14. McDowell TS, Chapleau MVV, Jajduuczak G, Abbund FM: Baroreflex dysfunction in diabetes mellitus I. Selective impairment of parasympathetic control of heart rate. Am J Physiol 1994, 266:H235-H243.
15. Dall'Ago P, Fernandes TG, Machado UF, Bello AA, Irigoyen MC: Baroreflex and chemoreflex dysfunction in streptozotocindiabetic rats. Broz J Med Biol Res 1997, 30(1):119-124.
16. Malone JI, Lowitt S, Salem AF: Sorbinil reverses peripheral diabetic neuropathy after 4 or 8, but not 16 weeks of untreated experimental Diabetes. Clin Res 1991, 39:837A.
17. Neely MR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974, 36:413-459.
18. Garvey WT, Hardin D, Juhaszova M, Dominguez JH: Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 1993, 264:H837-844.
19. Chatham JC, Forder JR: A 13C NMR study of glucose oxidation in the intact functioning rat heart following diabetes-induced cardiomyopathy. J Mol Cell Cordiol 1993, 10:1203-1213.
20. Oshima M, Higashi S, Kikuchi Y, Fukumitsu M, Ban S, Shiai T, Furui S, Yasukoc: Auutoradiographic study of myocardial fatty acid metabolism in diabetic mouse using 1251-SMIPP. Mippon Igaku Hoskasen Gakkai Zasshi 1996, 56:137-138.
21. Stroedter D, Schmidt T, Bretzel RG, Federlin K: Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat. Acta Diabetol 1995, 32:235-243.
22. Ponsot E, Zoll J, N'Guessan B, Ribera F, Lampert E, Richard R, Veksler V, Ventura-Clapier R, Mettauer B: Mitochondrial tissue specificity of substrates utilization in rat cardiac and skeletal muscles. J Cellular Physiology 2005, 203:479-486.
23. Bremer J: Carnitine-metabolism and functions. Physiol Rev 1983, 63:1420-1480.
24. Waber LJ, Valle D, Neill C, DiMauro S, Shug A: Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr 1982, 101:700-705.
25. Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25(4):543-67.
26. Broderick TL, Paulson DJ, Gillis M: Effects of propionyl-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart. Drugs RD 2004, 5(4):191-201.